J Menopausal Med.  2014 Dec;20(3):126-132. 10.6118/jmm.2014.20.3.126.

The Association between Serum Uric Acid Level and Incidence of Metabolic Syndrome according to Menopausal Status in Korean Women

• Joo JK
• Hong GP
• Han SE
• Lee YJ
• Kim SC
• Kim CW
• Lee KS

• KMID: 2325476
• DOI: http://doi.org/10.6118/jmm.2014.20.3.126

Abstract

OBJECTIVES
The aim of this study is to investigate the association between serum uric acid level and metabolic syndrome according to menopausal status in Korean women.
METHODS
A total of 2,241 women who visited to the health promotion center at Pusan National University Hospital from 2010 to 2014 were included in this cross-sectional study. Self-report questionnaires and interviews with healthcare providers were used to assess disease history, medication history, menstrual history and body size measuring. Anthropometric measurements and laboratory results were compared as presence of metabolic syndrome and menopausal status by student-t test. Logistic regression analysis was performed between presence of metabolic syndrome and presumable predictive factors, such as age, menopause and serum uric acid.
RESULTS
The prevalence rate of metabolic syndrome were 7.45% (63/846) in pre-menopausal group and 23.87% (333/1395) in menopausal group. Serum uric acid level was higher in menopausal women than premenopausal women (4.6 +/- 1.1 vs. 4.3 +/- 0.9. P = 0.000). And, its concentration was also higher in metabolic syndrome than normal women regarding of menopausal statue (premenopause 4.7 +/- 1.1 vs. 4.2 +/- 0.8, P = 0.001, menopause 4.9 +/- 1.3 vs. 4.5 +/- 1.0, P = 0.000). Multiple logistic regression analysis showed serum uric acid and age have relationship with metabolic syndrome (OR: 1.453, 95% confidence interval [CI]: 1.074-1.111, P = 0.000; OR: 1.092, 95% CI: 1.305-1.619, P = 0.000).
CONCLUSION
We could find out some potential of uric acid as predictive factor for metabolic syndrome in premenopausal and menopausal group. Further investigation is required to clarify the relationship between serum uric acid, menopause and metabolic syndrome.

Keyword

Menopause; Metabolic syndrome X; Uric acid

MeSH Terms

Body Size
Busan
Cross-Sectional Studies
Female
Health Personnel
Health Promotion
Humans
Incidence*
Logistic Models
Menopause
Metabolic Syndrome X
Prevalence
Surveys and Questionnaires
Uric Acid*
Uric Acid

Reference

1. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109:433–438.

2. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Executive summary. Cardiol Rev. 2005; 13:322–327.

3. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005; 112:3066–3072.

4. Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M, et al. Uric acid and the development of hypertension: the normative aging study. Hypertension. 2006; 48:1031–1036.

5. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol. 2003; 18:523–530.

6. Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism. 2006; 55:1293–1301.

7. Schmidt MI, Watson RL, Duncan BB, Metcalf P, Brancati FL, Sharrett AR, et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism. 1996; 45:699–706.

8. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J. 2005; 69:928–933.

9. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health. 2004; 4:9.

10. Vuorinen-Markkola H, Yki-Järvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab. 1994; 78:25–29.

11. Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of metabolic syndrome in women and men. Metabolism. 2008; 57:845–852.

12. Chen LK, Lin MH, Lai HY, Hwang SJ, Chiou ST. Uric acid: a surrogate of insulin resistance in older women. Maturitas. 2008; 59:55–61.

13. Lippi G, Montagnana M, Franchini M, Favaloro EJ, Targher G. The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta. 2008; 392:1–7.

14. Wolfson WQ, Hunt HD, et al. The transport and excretion of uric acid in man; a sex difference in urate metabolism; with a note on clinical and laboratory findings in gouty women. J Clin Endocrinol Metab. 1949; 9:749–767.

15. Scott JT, Pollard AC. Uric acid excretion in the relatives of patients with gout. Ann Rheum Dis. 1970; 29:397–400.

16. Nicholls A, Snaith ML, Scott JT. Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br Med J. 1973; 1:449–451.

17. Sumino H, Ichikawa S, Kanda T, Nakamura T, Sakamaki T. Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet. 1999; 354:650.

18. Antón FM, García Puig J, Ramos T, González P, Ordás J. Sex differences in uric acid metabolism in adults: evidence for a lack of influence of estradiol-17 beta (E2) on the renal handling of urate. Metabolism. 1986; 35:343–348.

19. Wingrove CS, Walton C, Stevenson JC. The effect of menopause on serum uric acid levels in non-obese healthy women. Metabolism. 1998; 47:435–438.

20. Rho YH, Woo JH, Choi SJ, Lee YH, Ji JD, Song GG. Association between serum uric acid and the Adult Treatment Panel III-defined metabolic syndrome: results from a single hospital database. Metabolism. 2008; 57:71–76.

21. National Cholesterol Education Program Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106:3143–3421.

22. Joo JK, Son JB, Jung JE, Kim SC, Lee KS. Differences of prevalence and components of metabolic syndrome according to menopausal status. J Korean Soc Menopause. 2012; 18:155–162.

23. Jeon SK, Hong HR, Yi KW, Park HT, Shin JH, Lee NW, et al. Relationship between metabolic syndrome and bone mineral density in middle-aged women. J Korean Soc Menopause. 2010; 16:142–147.

24. Kim HM, Park J, Ryu SY, Kim J. The effect of menopause on the metabolic syndrome among Korean women: the Korean National Health and Nutrition Examination Survey, 2001. Diabetes Care. 2007; 30:701–706.

25. Cho GJ, Park HT, Shin JH, Kim T, Hur JY, Kim YT, et al. The relationship between reproductive factors and metabolic syndrome in Korean postmenopausal women: Korea National Health and Nutrition Survey 2005. Menopause. 2009; 16:998–1003.

26. Hak AE, Choi HK. Menopause, postmenopausal hormone use and serum uric acid levels in US women-the Third National Health and Nutrition Examination Survey. Arthritis Res Ther. 2008; 10:R116.

27. Ozbey N, Sencer E, Molvalilar S, Orhan Y. Body fat distribution and cardiovascular disease risk factors in pre- and postmenopausal obese women with similar BMI. Endocr J. 2002; 49:503–509.

28. Cremonini E, Bonaccorsi G, Bergamini CM, Castaldini C, Ferrazzini S, Capatti A, et al. Metabolic transitions at menopause: in post-menopausal women the increase in serum uric acid correlates with abdominal adiposity as assessed by DXA. Maturitas. 2013; 75:62–66.

29. Schachter M. Uric acid and hypertension. Curr Pharm Des. 2005; 11:4139–4143.

30. Han M. Metabolic syndrome emerging from menopause. J Korean Soc Menopause. 2011; 17:127–135.